Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Oral Solid Dosage Form Excipients Market Report 2017

  • QYR1651343
  • 121 Pages
  • September 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Oral Solid Dosage Form Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Oral Solid Dosage Form Excipients in these regions, from 2012 to 2022 (forecast).

United States Oral Solid Dosage Form Excipients market competition by top manufacturers/players, with Oral Solid Dosage Form Excipients sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Abitec

Ashland

BASF

Croda

Dow

Evonik

Gattefosse

Shin-Etsu

Clariant

Cytec

Disruptive Materials

FMC BioPolymer

Freund

Fuji Chemical Industry

Indion

Maple Biotech

Merck Millipore

Peter Cremer

Purolite

Roquette

Seppic

SPI Phrama

Stepan

Sumitomo Chemical

Thermax

Wacker Chemie

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Type I

Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oral Solid Dosage Form Excipients for each application, including

Oral Solid Dosage Form

Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Oral Solid Dosage Form Excipients Market Report 2017

1 Oral Solid Dosage Form Excipients Overview

1.1 Product Overview and Scope of Oral Solid Dosage Form Excipients

1.2 Classification of Oral Solid Dosage Form Excipients by Product Category

1.2.1 United States Oral Solid Dosage Form Excipients Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Oral Solid Dosage Form Excipients Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3

1.2.4

1.3 United States Oral Solid Dosage Form Excipients Market by Application/End Users

1.3.1 United States Oral Solid Dosage Form Excipients Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Oral Solid Dosage Form

1.3.3 Other

1.4 United States Oral Solid Dosage Form Excipients Market by Region

1.4.1 United States Oral Solid Dosage Form Excipients Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Oral Solid Dosage Form Excipients Status and Prospect (2012-2022)

1.4.3 Southwest Oral Solid Dosage Form Excipients Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Oral Solid Dosage Form Excipients Status and Prospect (2012-2022)

1.4.5 New England Oral Solid Dosage Form Excipients Status and Prospect (2012-2022)

1.4.6 The South Oral Solid Dosage Form Excipients Status and Prospect (2012-2022)

1.4.7 The Midwest Oral Solid Dosage Form Excipients Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Oral Solid Dosage Form Excipients (2012-2022)

1.5.1 United States Oral Solid Dosage Form Excipients Sales and Growth Rate (2012-2022)

1.5.2 United States Oral Solid Dosage Form Excipients Revenue and Growth Rate (2012-2022)

2 United States Oral Solid Dosage Form Excipients Market Competition by Players/Suppliers

2.1 United States Oral Solid Dosage Form Excipients Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Oral Solid Dosage Form Excipients Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Oral Solid Dosage Form Excipients Average Price by Players/Suppliers (2012-2017)

2.4 United States Oral Solid Dosage Form Excipients Market Competitive Situation and Trends

2.4.1 United States Oral Solid Dosage Form Excipients Market Concentration Rate

2.4.2 United States Oral Solid Dosage Form Excipients Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Oral Solid Dosage Form Excipients Manufacturing Base Distribution, Sales Area, Product Type

3 United States Oral Solid Dosage Form Excipients Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Oral Solid Dosage Form Excipients Sales and Market Share by Region (2012-2017)

3.2 United States Oral Solid Dosage Form Excipients Revenue and Market Share by Region (2012-2017)

3.3 United States Oral Solid Dosage Form Excipients Price by Region (2012-2017)

4 United States Oral Solid Dosage Form Excipients Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Oral Solid Dosage Form Excipients Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Oral Solid Dosage Form Excipients Revenue and Market Share by Type (2012-2017)

4.3 United States Oral Solid Dosage Form Excipients Price by Type (2012-2017)

4.4 United States Oral Solid Dosage Form Excipients Sales Growth Rate by Type (2012-2017)

5 United States Oral Solid Dosage Form Excipients Sales (Volume) by Application (2012-2017)

5.1 United States Oral Solid Dosage Form Excipients Sales and Market Share by Application (2012-2017)

5.2 United States Oral Solid Dosage Form Excipients Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Oral Solid Dosage Form Excipients Players/Suppliers Profiles and Sales Data

6.1 Abitec

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Abitec Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Ashland

6.2.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Ashland Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 BASF

6.3.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 BASF Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Croda

6.4.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Croda Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Dow

6.5.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Dow Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Evonik

6.6.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Evonik Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Gattefosse

6.7.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Gattefosse Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Shin-Etsu

6.8.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Shin-Etsu Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Clariant

6.9.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Clariant Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Cytec

6.10.2 Oral Solid Dosage Form Excipients Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Cytec Oral Solid Dosage Form Excipients Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Disruptive Materials

6.12 FMC BioPolymer

6.13 Freund

6.14 Fuji Chemical Industry

6.15 Indion

6.16 Maple Biotech

6.17 Merck Millipore

6.18 Peter Cremer

6.19 Purolite

6.20 Roquette

6.21 Seppic

6.22 SPI Phrama

6.23 Stepan

6.24 Sumitomo Chemical

6.25 Thermax

6.26 Wacker Chemie

7 Oral Solid Dosage Form Excipients Manufacturing Cost Analysis

7.1 Oral Solid Dosage Form Excipients Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Oral Solid Dosage Form Excipients

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Oral Solid Dosage Form Excipients Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Oral Solid Dosage Form Excipients Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Oral Solid Dosage Form Excipients Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Oral Solid Dosage Form Excipients Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Oral Solid Dosage Form Excipients Sales Volume Forecast by Type (2017-2022)

11.3 United States Oral Solid Dosage Form Excipients Sales Volume Forecast by Application (2017-2022)

11.4 United States Oral Solid Dosage Form Excipients Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Oral Solid Dosage Form Excipients

Figure United States Oral Solid Dosage Form Excipients Market Size (K Units) by Type (2012-2022)

Figure United States Oral Solid Dosage Form Excipients Sales Volume Market Share by Type (Product Category) in 2016

Figure Type I Product Picture

Figure Type II Product Picture

Figure United States Oral Solid Dosage Form Excipients Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Oral Solid Dosage Form Excipients by Application in 2016

Figure Oral Solid Dosage Form Examples

Table Key Downstream Customer in Oral Solid Dosage Form

Figure Other Examples

Table Key Downstream Customer in Other

Figure United States Oral Solid Dosage Form Excipients Market Size (Million USD) by Region (2012-2022)

Figure The West Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Oral Solid Dosage Form Excipients Sales (K Units) and Growth Rate (2012-2022)

Figure United States Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Oral Solid Dosage Form Excipients Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Oral Solid Dosage Form Excipients Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Oral Solid Dosage Form Excipients Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Oral Solid Dosage Form Excipients Sales Share by Players/Suppliers

Figure 2017 United States Oral Solid Dosage Form Excipients Sales Share by Players/Suppliers

Figure United States Oral Solid Dosage Form Excipients Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Oral Solid Dosage Form Excipients Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Oral Solid Dosage Form Excipients Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Oral Solid Dosage Form Excipients Revenue Share by Players/Suppliers

Figure 2017 United States Oral Solid Dosage Form Excipients Revenue Share by Players/Suppliers

Table United States Market Oral Solid Dosage Form Excipients Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Oral Solid Dosage Form Excipients Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Oral Solid Dosage Form Excipients Market Share of Top 3 Players/Suppliers

Figure United States Oral Solid Dosage Form Excipients Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Oral Solid Dosage Form Excipients Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Oral Solid Dosage Form Excipients Product Category

Table United States Oral Solid Dosage Form Excipients Sales (K Units) by Region (2012-2017)

Table United States Oral Solid Dosage Form Excipients Sales Share by Region (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Sales Share by Region (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Sales Market Share by Region in 2016

Table United States Oral Solid Dosage Form Excipients Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Oral Solid Dosage Form Excipients Revenue Share by Region (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Revenue Market Share by Region (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Revenue Market Share by Region in 2016

Table United States Oral Solid Dosage Form Excipients Price (USD/Unit) by Region (2012-2017)

Table United States Oral Solid Dosage Form Excipients Sales (K Units) by Type (2012-2017)

Table United States Oral Solid Dosage Form Excipients Sales Share by Type (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Sales Share by Type (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Sales Market Share by Type in 2016

Table United States Oral Solid Dosage Form Excipients Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Oral Solid Dosage Form Excipients Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Oral Solid Dosage Form Excipients by Type (2012-2017)

Figure Revenue Market Share of Oral Solid Dosage Form Excipients by Type in 2016

Table United States Oral Solid Dosage Form Excipients Price (USD/Unit) by Types (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Sales Growth Rate by Type (2012-2017)

Table United States Oral Solid Dosage Form Excipients Sales (K Units) by Application (2012-2017)

Table United States Oral Solid Dosage Form Excipients Sales Market Share by Application (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Sales Market Share by Application (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Sales Market Share by Application in 2016

Table United States Oral Solid Dosage Form Excipients Sales Growth Rate by Application (2012-2017)

Figure United States Oral Solid Dosage Form Excipients Sales Growth Rate by Application (2012-2017)

Table Abitec Basic Information List

Table Abitec Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Abitec Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Abitec Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Abitec Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Ashland Basic Information List

Table Ashland Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Ashland Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Ashland Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Ashland Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table BASF Basic Information List

Table BASF Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure BASF Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure BASF Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure BASF Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Croda Basic Information List

Table Croda Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Croda Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Croda Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Croda Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Dow Basic Information List

Table Dow Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Dow Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Dow Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Dow Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Evonik Basic Information List

Table Evonik Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Evonik Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Evonik Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Evonik Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Gattefosse Basic Information List

Table Gattefosse Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Gattefosse Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Gattefosse Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Gattefosse Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Shin-Etsu Basic Information List

Table Shin-Etsu Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Shin-Etsu Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Shin-Etsu Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Shin-Etsu Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Clariant Basic Information List

Table Clariant Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Clariant Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Clariant Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Clariant Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Cytec Basic Information List

Table Cytec Oral Solid Dosage Form Excipients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Cytec Oral Solid Dosage Form Excipients Sales Growth Rate (2012-2017)

Figure Cytec Oral Solid Dosage Form Excipients Sales Market Share in United States (2012-2017)

Figure Cytec Oral Solid Dosage Form Excipients Revenue Market Share in United States (2012-2017)

Table Disruptive Materials Basic Information List

Table FMC BioPolymer Basic Information List

Table Freund Basic Information List

Table Fuji Chemical Industry Basic Information List

Table Indion Basic Information List

Table Maple Biotech Basic Information List

Table Merck Millipore Basic Information List

Table Peter Cremer Basic Information List

Table Purolite Basic Information List

Table Roquette Basic Information List

Table Seppic Basic Information List

Table SPI Phrama Basic Information List

Table Stepan Basic Information List

Table Sumitomo Chemical Basic Information List

Table Thermax Basic Information List

Table Wacker Chemie Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Oral Solid Dosage Form Excipients

Figure Manufacturing Process Analysis of Oral Solid Dosage Form Excipients

Figure Oral Solid Dosage Form Excipients Industrial Chain Analysis

Table Raw Materials Sources of Oral Solid Dosage Form Excipients Major Players/Suppliers in 2016

Table Major Buyers of Oral Solid Dosage Form Excipients

Table Distributors/Traders List

Figure United States Oral Solid Dosage Form Excipients Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Oral Solid Dosage Form Excipients Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Oral Solid Dosage Form Excipients Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Oral Solid Dosage Form Excipients Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Oral Solid Dosage Form Excipients Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Oral Solid Dosage Form Excipients Sales Volume (K Units) Forecast by Type in 2022

Table United States Oral Solid Dosage Form Excipients Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Oral Solid Dosage Form Excipients Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Oral Solid Dosage Form Excipients Sales Volume (K Units) Forecast by Application in 2022

Table United States Oral Solid Dosage Form Excipients Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Oral Solid Dosage Form Excipients Sales Volume Share Forecast by Region (2017-2022)

Figure United States Oral Solid Dosage Form Excipients Sales Volume Share Forecast by Region (2017-2022)

Figure United States Oral Solid Dosage Form Excipients Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370